Federal Circuit affirms ruling to reject flu patent

19-10-2016

Federal Circuit affirms ruling to reject flu patent

tonefotografia / shutterstock.com

The US Court of Appeals for the Federal Circuit has affirmed the Patent Trial and Appeal Board’s (PTAB) decision to reject a patent application centring on an influenza drug.


USPTO, PTAB, Relenza, patent application, patent, zanamivir, influenza, Federal Circuit

LSIPR